The Synthesis of Spirocyclopropane Skeletons Enabled by Rh(III)-catalyzed Enantioselective C–H Activation/[4 + 2] Annulation
Hao Wang,Yidi Li,Lin Huang,Huiying Xu,Yukun Jiao,Zhi Zhou,Zhenhao Tang,Feifei Fang,Xiaoxue Zhang,Kan Ding,Wei Yi,Hong Liu,Xiaowei Wu,Yu Zhou
DOI: https://doi.org/10.1016/j.checat.2023.100822
2023-01-01
Chem Catalysis
Abstract:Considering the prevalence of spirocyclopropane motifs in bioac-tive compounds, the development of efficient methods for the syn-thesis of various chiral spirocyclopropane motifs would be highly desirable but challenging. Herein, we report an asymmetric synthe-sis of spirocyclopropane skeletons enabled by a chiral CpmRh-cata-lyzed C-H activation/[4 + 2] annulation of aromatic substrates (e.g., indole, pyrrole, benzene, naphthalene, thiophene) and acryl-amides with methylenecyclopropanes (MCPs). Notably, we realized an asymmetric C(sp2)-H activation/annulati on cascade with multi -substituted non-cyclic alkenes catalyzed by a chiral 1,1'-Bi-2-naph-thol (BINOL )-derived CpmRh(III) catalyst, in which diverse spirocyclo-propane scaffolds were prepared with good to excellent yields and enantioselectivities (up to 98% yield, up to 99.7:0.3 er). Density functional theory (DFT) studies prove that the energy barrier of the product configuration is low in the whole reaction process. Furthermore, the spirocyclopropane product (S)-3aj exhibited a bet-ter antiproliferation activity against the pancreatic cancer cell line BxPC-3 and could be a good lead compound for further anti -pancre-atic-tumor drug development.